Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression

10.1093/rheumatology/kep120

Saved in:
Bibliographic Details
Main Authors: Mak, A., Cheak, A.A.C., Tan, J.Y.S., Su, H.C., Ho, R.C.M., Lau, C.S.
Other Authors: MEDICINE
Format: Article
Published: 2011
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/27137
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-27137
record_format dspace
spelling sg-nus-scholar.10635-271372023-10-29T22:37:06Z Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression Mak, A. Cheak, A.A.C. Tan, J.Y.S. Su, H.C. Ho, R.C.M. Lau, C.S. MEDICINE PSYCHOLOGICAL MEDICINE Cyclophosphamide Lupus Meta-analysis Meta-regression Mycophenolate Nephritis 10.1093/rheumatology/kep120 Rheumatology 48 8 944-952 2011-09-27T05:45:09Z 2011-09-27T05:45:09Z 2009 Article Mak, A., Cheak, A.A.C., Tan, J.Y.S., Su, H.C., Ho, R.C.M., Lau, C.S. (2009). Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression. Rheumatology 48 (8) : 944-952. ScholarBank@NUS Repository. https://doi.org/10.1093/rheumatology/kep120 14620324 14620332 http://scholarbank.nus.edu.sg/handle/10635/27137 000268109000017 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Cyclophosphamide
Lupus
Meta-analysis
Meta-regression
Mycophenolate
Nephritis
spellingShingle Cyclophosphamide
Lupus
Meta-analysis
Meta-regression
Mycophenolate
Nephritis
Mak, A.
Cheak, A.A.C.
Tan, J.Y.S.
Su, H.C.
Ho, R.C.M.
Lau, C.S.
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
description 10.1093/rheumatology/kep120
author2 MEDICINE
author_facet MEDICINE
Mak, A.
Cheak, A.A.C.
Tan, J.Y.S.
Su, H.C.
Ho, R.C.M.
Lau, C.S.
format Article
author Mak, A.
Cheak, A.A.C.
Tan, J.Y.S.
Su, H.C.
Ho, R.C.M.
Lau, C.S.
author_sort Mak, A.
title Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
title_short Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
title_full Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
title_fullStr Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
title_full_unstemmed Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
title_sort mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression
publishDate 2011
url http://scholarbank.nus.edu.sg/handle/10635/27137
_version_ 1781410575851454464